Juanita Wizniak
Overview
Explore the profile of Juanita Wizniak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Z, Wizniak J, Shang C, Lai R
Arch Pathol Lab Med
. 2021 Sep;
146(6):718-726.
PMID: 34506624
Context.—: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is characterized by neoplastic lymphocyte-predominant cells frequently rimmed by CD3+/CD57+/programmed death receptor-1 (PD-1)+ T cells. Because of the rarity of lymphocyte-predominant cells in most...
2.
Mykhailova O, Turner T, Olafson C, Howell A, Nahirniak S, Wizniak J, et al.
Transfusion
. 2021 Jan;
61(4):1247-1257.
PMID: 33481275
Background: Irradiation of red blood cells (RBCs) inactivates residual donor T lymphocytes to prevent transfusion-associated graft-vs-host disease (TA-GVHD) but can have adverse effects on recipients and inventory management. Reported incidence...
3.
Slack G, Wizniak J, Dabbagh L, Shi X, Gelebart P, Lai R
Arch Pathol Lab Med
. 2007 Jan;
131(1):50-6.
PMID: 17227123
Context: Expression of ZAP-70 in chronic lymphocytic leukemia (CLL) predicts worse clinical outcome in patients with early-stage disease. It has become important to include ZAP-70 in the immunophenotyping panel used...
4.
Taylor B, Kriangkum J, Strachan E, Wizniak J, Pilarski L
Methods Mol Med
. 2005 Jun;
113:121-44.
PMID: 15968099
In multiple myeloma (MM) the rearranged immunoglobulin heavy chain (IgH) variable, diversity, and joining (VDJ) DNA sequence of malignant plasma cells (PCs) serves as a marker for cells in the...
5.
Enns L, Bogen K, Wizniak J, Murtha A, Weinfeld M
Mol Cancer Res
. 2004 Oct;
2(10):557-66.
PMID: 15498930
Exposure to environmental radiation and the application of new clinical modalities, such as radioimmunotherapy, have heightened the need to understand cellular responses to low dose and low-dose rate ionizing radiation....